Articles by Disease (Diabetic Cardiomyopathies)

NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment

Journal: Current Medicinal Chemistry
Volume: 25
Page: 404-432
Author(s): Ana Fernandez-Marmiesse*, Sofia Gouveia and Maria L. Couce *

Attenuation of Diabetes-induced Cardiac and Subcellular Defects by Sulphur-containing Amino Acids

Journal: Current Medicinal Chemistry
Volume: 25
Page: 336-345
Author(s): Paramjit S. Tappia*, Adriana Adameova and Naranjan S. Dhalla

Phyto-glycosides as Therapeutic Target in the Treatment of Diabetes

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18
Page: 208-215
Author(s): Sumaira Khattak and Haroon Khan*

Effects of Apelin Peptides on Diabetic Complications

Journal: Current Protein & Peptide Science
Volume: 19
Page: 179-189
Author(s): Hong Chen, Chengyu Liu, Cheng Cheng, Ling Zheng and Kun Huang*

Uncontrolled Hypertension and Oncology: Clinical Tips

Journal: Current Vascular Pharmacology
Volume: 16
Page: 23-29
Author(s): Rigas G. Kalaitzidis* and Moses S. Elisaf

Renin-Angiotensin System in Diabetes

Journal: Protein & Peptide Letters
Volume: 24
Page: 833-840
Author(s): Johannes Rein and Michael Bader*

Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics

Journal: Current Cardiology Reviews
Volume: 13
Page: 301-304
Author(s): Chayakrit Krittanawong*, Tao Sun and Eyal Herzog

Bayes Syndrome and Imaging Techniques

Journal: Current Cardiology Reviews
Volume: 13
Page: 263-273
Author(s): Ivan Hernandez-Betancor, Maria Manuela Izquierdo-Gomez, Javier Garcia-Niebla, Ignacio Laynez-Cerdena, Martin Jesus Garcia-Gonzalez, A. Barragan-Acea, Jose Luis Irribarren- Sarria, Juan Jose Jimenez-Rivera and Juan Lacalzada-Almeida*

Targeting Apelinergic System in Cardiometabolic Disease

Journal: Current Drug Targets
Volume: 18
Page: 1785-1791
Author(s): Rui Guo, Olivia Rogers and Sreejayan Nair*

Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease

Journal: Current Drug Targets
Volume: 18
Page: 1817-1823
Author(s): Xiangwei Liu and Aijun Sun*